These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 39003338)

  • 1. Computational screening combined with well-tempered metadynamics simulations identifies potential TMPRSS2 inhibitors.
    Sharanya CS; Wilbee DS; Sathi SN; Natarajan K
    Sci Rep; 2024 Jul; 14(1):16197. PubMed ID: 39003338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Basis of Covalent Inhibitory Mechanism of TMPRSS2-Related Serine Proteases by Camostat.
    Sun G; Sui Y; Zhou Y; Ya J; Yuan C; Jiang L; Huang M
    J Virol; 2021 Sep; 95(19):e0086121. PubMed ID: 34160253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.
    Vivek-Ananth RP; Rana A; Rajan N; Biswal HS; Samal A
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32842606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong Binding of Leupeptin with TMPRSS2 Protease May Be an Alternative to Camostat and Nafamostat for SARS-CoV-2 Repurposed Drug: Evaluation from Molecular Docking and Molecular Dynamics Simulations.
    Ramakrishnan J; Kandasamy S; Iruthayaraj A; Magudeeswaran S; Chinnasamy K; Poomani K
    Appl Biochem Biotechnol; 2021 Jun; 193(6):1909-1923. PubMed ID: 33512650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2).
    Rahman N; Basharat Z; Yousuf M; Castaldo G; Rastrelli L; Khan H
    Molecules; 2020 May; 25(10):. PubMed ID: 32408547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein.
    Manjunathan R; Periyaswami V; Mitra K; Rosita AS; Pandya M; Selvaraj J; Ravi L; Devarajan N; Doble M
    BMC Bioinformatics; 2022 May; 23(1):180. PubMed ID: 35578172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies.
    Kishk SM; Kishk RM; Yassen ASA; Nafie MS; Nemr NA; ElMasry G; Al-Rejaie S; Simons C
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33137894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2.
    Huggins DJ
    J Mol Graph Model; 2020 Nov; 100():107710. PubMed ID: 32829149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of 13 Guanidinobenzoyl- or Aminidinobenzoyl-Containing Drugs to Potentially Inhibit TMPRSS2 for COVID-19 Treatment.
    Huang X; Pearce R; Omenn GS; Zhang Y
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine.
    Prasad K; Ahamad S; Kanipakam H; Gupta D; Kumar V
    ACS Chem Neurosci; 2021 Mar; 12(5):930-944. PubMed ID: 33606519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of ACE2 variant N720D demonstrates a higher binding affinity to TMPRSS2.
    Mohammad A; Marafie SK; Alshawaf E; Abu-Farha M; Abubaker J; Al-Mulla F
    Life Sci; 2020 Oct; 259():118219. PubMed ID: 32768580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.
    Ahmad S; Waheed Y; Abro A; Abbasi SW; Ismail S
    J Mol Model; 2021 Jun; 27(7):206. PubMed ID: 34169390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-silico screening for identification of potential inhibitors against SARS-CoV-2 transmembrane serine protease 2 (TMPRSS2).
    Barge S; Jade D; Gosavi G; Talukdar NC; Borah J
    Eur J Pharm Sci; 2021 Jul; 162():105820. PubMed ID: 33775827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unravelling high-affinity binding compounds towards transmembrane protease serine 2 enzyme in treating SARS-CoV-2 infection using molecular modelling and docking studies.
    M P; Reddy GJ; Hema K; Dodoala S; Koganti B
    Eur J Pharmacol; 2021 Jan; 890():173688. PubMed ID: 33130280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel TMPRSS2 inhibitors against SARS-CoV-2 infection: a structure-based virtual screening and molecular dynamics study.
    Manandhar S; Pai KSR; Krishnamurthy PT; Kiran AVVVR; Kumari GK
    Struct Chem; 2022; 33(5):1529-1541. PubMed ID: 35345416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DON/DRP-104 as potent serine protease inhibitors implicated in SARS-CoV-2 infection: Comparative binding modes with human TMPRSS2 and novel therapeutic approach.
    Oduro-Kwateng E; Soliman ME
    J Cell Biochem; 2024 Oct; 125(10):e30528. PubMed ID: 38284235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, virtual screening and molecular dynamic analysis of novel TMPRSS2 inhibitors from natural compound database as potential entry-blocking agents in SARS-CoV-2 therapy.
    Manandhar S; Pai KSR; Krishnamurthy PT; Kiran AVVVR; Kumari GK
    Struct Chem; 2022; 33(5):1609-1617. PubMed ID: 35754942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Screening of Novel TMPRSS2 Inhibitors for Treatment of COVID-19.
    Wang S; Fang X; Wang Y
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection.
    Wettstein L; Weil T; Conzelmann C; Müller JA; Groß R; Hirschenberger M; Seidel A; Klute S; Zech F; Prelli Bozzo C; Preising N; Fois G; Lochbaum R; Knaff PM; Mailänder V; Ständker L; Thal DR; Schumann C; Stenger S; Kleger A; Lochnit G; Mayer B; Ruiz-Blanco YB; Hoffmann M; Sparrer KMJ; Pöhlmann S; Sanchez-Garcia E; Kirchhoff F; Frick M; Münch J
    Nat Commun; 2021 Mar; 12(1):1726. PubMed ID: 33741941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting mechanism for SARS-CoV-2
    Zhao X; Luo S; Huang K; Xiong D; Zhang JZH; Duan L
    Nanoscale; 2021 Nov; 13(45):19218-19237. PubMed ID: 34787160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.